This inventor holds 1 USPTO granted patent. Top assignee: Shorla Pharma Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Frodsham: Pharmaceutical Formulation Inventor
Introduction
Michael Frodsham is an inventor associated with Flintshire, Great Britain, and Shorla Pharma Limited. His patent work concerns a liquid formulation of methotrexate, a medicine used in therapy.
Latest Patents
The available information identifies one patent associated with Frodsham: “Methotrexate formulation.” It describes a liquid pharmaceutical composition containing methotrexate free acid and a buffer, with a pH between 6.5 and 8.2. The patent also describes processes for preparing the composition and notes its potential use in therapy. The supplied information does not establish when this patent was published or whether it is his latest filing. Frodsham is associated with 1 patent.
Career Highlights
Frodsham’s identified patent highlights work on pharmaceutical formulation and preparation processes. The composition’s specified pH range and use of methotrexate free acid are central features of the invention.
Collaborations
Frodsham is associated with Shorla Pharma Limited. Julie-Ann Penton is identified as his coworker.
Conclusion
Michael Frodsham’s documented invention focuses on a buffered liquid methotrexate formulation and its preparation, reflecting pharmaceutical innovation associated with Shorla Pharma Limited.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile